Lyell Immunopharma

URI: https://gptkb.org/entity/Lyell_Immunopharma
GPTKB entity
Statements (23)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:CEO gptkb:Rick_Klausner
gptkbp:collaboratesWith gptkb:Fred_Hutchinson_Cancer_Research_Center
GlaxoSmithKline
gptkbp:focusesOn gptkb:gene_therapy
gptkb:immunotherapy
gptkb:cancer
gptkbp:foundedYear 2018
gptkbp:founder gptkb:Rick_Klausner
gptkbp:headquartersLocation gptkb:South_San_Francisco,_California,_United_States
gptkbp:industry gptkb:biotechnology
gptkbp:notableProduct gptkb:LYL132
gptkb:LYL797
LYL845
gptkbp:publiclyTraded yes
gptkbp:specializesIn T-cell therapies
gptkbp:stockExchange gptkb:NASDAQ
gptkbp:stockSymbol gptkb:LYEL
gptkbp:website https://www.lyell.com/
gptkbp:bfsParent gptkb:Hans_Bishop
gptkb:Richard_Klausner
gptkbp:bfsLayer 6
https://www.w3.org/2000/01/rdf-schema#label Lyell Immunopharma